Platelet Function in Patients Undergoing PCI
December 27, 2010 updated by: Rambam Health Care Campus
The purpose of this study is to examine PLT function in PCI patients.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel, 31096
- Recruiting
- Rambam Medical Center
-
Contact:
- Ariel Roguin, MD PhD
- Phone Number: 972-4-854-2181
- Email: a_roguin@rambam.health.gov.il
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
To examine PLT function in all patients undergoing PCI to our center
Description
Inclusion Criteria:
- All consented patients undergoing PCI
Exclusion Criteria:
- Unable to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Study Group
All those tested
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Study Registration Dates
First Submitted
December 27, 2010
First Submitted That Met QC Criteria
December 27, 2010
First Posted (Estimate)
December 28, 2010
Study Record Updates
Last Update Posted (Estimate)
December 28, 2010
Last Update Submitted That Met QC Criteria
December 27, 2010
Last Verified
November 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- 431-10 CTIL
- 431-10.2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on All PCI Patients
-
AstraZenecaWithdrawn
-
Abiomed Inc.CompletedPatients Undergoing High Risk PCI.United States, Netherlands
-
Shanghai Zhongshan HospitalRecruiting
-
Yonsei UniversityWithdrawnPatients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
-
Assiut UniversityNot yet recruitingAcute Myocardial Infarction (AMI) | Percutaneous Coronary Intervention (PCI) | Left Ventricle Remodeling | Primary Percutaneous Coronary Intervention | PCI Patients
-
Hospital Clinic of BarcelonaAstraZenecaCompletedPatients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)Spain
-
RWTH Aachen UniversityWithdrawnPatients With SAT or LT After Stent Implantation (PCI)Germany
-
Fujian Medical University Union HospitalNot yet recruitingPCI Patients | DAPT(Dual Antiplatelet Therapy) | Hip Fracture Surgeries
-
Fondazione GISE OnlusUniversity of Padova; Abiomed Inc.Recruiting
-
Shanghai Dynaheart Medtech Co., Ltd.The Second Hospital of Hebei Medical University; First Affiliated Hospital,... and other collaboratorsActive, not recruiting